Bryant Davis Uy, PA-C

Bryant Uy practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Bryant Uy's NPI, 1346509213, was assigned on May 11, 2012. Bryant Uy holds California license PA22077.

Bryant Uy's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Bryant Uy's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Attune Health. Dmand AI also links Bryant Uy to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bryant Uy practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Bryant Uy's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Bryant Uy is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Bryant Uy is licensed in California.

Dmand AI lists arteritis, arthritis, bursitis, hand joint or tendon inflammation, lower back pain, neck pain and spine problems, osteoporosis and psoriasis among the conditions Bryant Uy treats.

CMS data shows 4,089 Medicare services from Bryant Uy across 13 procedure codes in 2024, for 204 Medicare patients. Medicare paid $98,549 for them. Every service was in an office.

CMS counts 204 Medicare patients who saw Bryant Uy in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have arthritis, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bryant Uy's median patient age at 78, with 79% women.

In 2024, Bryant Uy wrote 1,644 Medicare Part D claims for 302 patients. 82% of them were for generic drugs. CMS names the drug for 1,287 of them, across 35 drugs with 11 or more claims each, at $997,035 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Bryant Uy for performance year 2024, reported as part of a group. Bryant Uy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Bryant Uy as offering telehealth.

CMS Open Payments shows 347 general payments to Bryant Uy from 31 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $1,975.